A new artificial intelligence (AI) solution for musculoskeletal imaging has been launched by ImageBiopsy Lab, a leading provider in the field. The company’s latest innovation, IB Lab FROG, is designed to enhance the accuracy and efficiency of foot pathology assessments using X-ray imaging. This AI-powered module has been cleared under the European Medical Device Regulation (MDR) and offers a comprehensive suite of automated measurements aimed at improving the diagnosis and management of foot disorders.
Foot pathologies affect a significant portion of the population, with estimates suggesting that between 61% and 79% of individuals suffer from some form of foot condition, a number that rises with age. The accurate assessment of these conditions often relies on radiographic measurements, yet traditional manual methods can be prone to inconsistency and are time-consuming, which may impact both treatment decisions and patient outcomes.
IB Lab FROG aims to address these issues by automating the process of measuring key foot conditions, making it quicker and more reliable. The AI module is designed to cover the five most common use cases in foot assessment, specifically using dorsal-plantar and lateral X-ray images. It provides a total of 17 measurements that are based on established radiological and orthopedic standards. The result is a highly consistent, standardised, and precise approach to diagnosing foot disorders, ensuring greater accuracy in clinical settings.
The module delivers its findings in a format compatible with any certified medical DICOM (Digital Imaging and Communications in Medicine) viewer, meaning it can be easily integrated into existing healthcare systems. The comprehensive report generated by IB Lab FROG can be reviewed by clinicians, allowing for swift decision-making and better treatment outcomes. This seamless integration into current clinical workflows enhances the overall efficiency of foot assessments, reducing the time needed for analysis and enabling clinicians to focus more on patient care.
Richard Ljuhar, CEO and Co-Founder of ImageBiopsy Lab, highlighted the module’s capabilities: “IB Lab FROG surpasses currently available algorithms by offering a comprehensive set of 17 measurements across five use cases, transforming the way clinicians assess foot conditions. With standardized and quantifiable data, IB Lab FROG streamlines workflows and supports informed treatment decisions.”
The launch of IB Lab FROG is a significant step in expanding ImageBiopsy Lab’s portfolio of AI-powered musculoskeletal solutions. The company now offers six CE-cleared musculoskeletal AI modules, each designed to assist healthcare professionals in delivering high-quality care. As the field of musculoskeletal diagnostics continues to evolve, ImageBiopsy Lab’s innovative AI solutions are helping to improve diagnostic accuracy, clinical efficiency, and patient outcomes.
With the introduction of IB Lab FROG, ImageBiopsy Lab reaffirms its commitment to advancing the field of musculoskeletal diagnostics. By combining cutting-edge AI technology with standardised diagnostic procedures, the company is set to make a substantial impact on the future of foot pathology assessments, improving the way clinicians diagnose and treat foot disorders across the globe.
